Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Annexin Pharmaceuticals (publ) via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2024-01-18 08:30:00
Annexin Pharmaceuticals today announces that the company is participating at Redeye’s theme event Fight Cancer on January 24, 2024. CEO Anders Haegerstrand will present the latest development in the company’s cancer initiative with the drug candidate ANXV.
The presentation and moderated Q&A session will be held in English and is broadcasted live via Redeye’s website https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2?tab=schedule
The presentation will also be available at Annexin’s website afterwards at https://annexinpharma.se/investerare/presentationer/
Time: January 2024 at 15:56 CET
Place: Redeye, Mäster Samuelsgatan 42, Stockholm